← All trials
NCT04407286
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 19, 2020
- Primary completion
- Aug 18, 2020
- Completion date
- May 18, 2021
- First posted
- May 29, 2020
- Last posted
- May 29, 2020
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Arizona State UniversityLead sponsor
- Arizona State UniversityOverall official - principal investigator
- Southwest College of Naturopathic MedicineCollaborator
- Southwest College of Naturopathic MedicineOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.